Trials / Completed
CompletedNCT04684992
GEBT Telehealth Administration Usability Study
Telehealth Administration of 13C-Spirulina Gastric Emptying Breath Test (13C-GEBT) Usability Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Cairn Diagnostics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to establish the usability of a telehealth platform for the administration of GEBT.
Detailed description
This study is intended to demonstrate that the 13C-Spirulina Gastric Emptying Breath Test (GEBT) can be successfully administered via a telehealth platform. Telehealth administration of GEBT is where a trained Cairn employee uses a video link to remotely supervise the completion of the test request form, collection of breath samples, cooking and consumption of the test meal and return of breath samples by the patient to Cairn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GEBT Telehealth Administration Usability | Establish the usability of a telehealth platform for the administration of GEBT |
Timeline
- Start date
- 2020-12-11
- Primary completion
- 2021-03-10
- Completion
- 2021-03-10
- First posted
- 2020-12-28
- Last updated
- 2021-08-24
- Results posted
- 2021-08-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04684992. Inclusion in this directory is not an endorsement.